Abstract

Vascular senescence is thought to play a crucial role in an ageing-associated decline of organ functions; however, whether vascular senescence is causally implicated in age-related disease remains unclear. Here we show that endothelial cell (EC) senescence induces metabolic disorders through the senescence-associated secretory phenotype. Senescence-messaging secretomes from senescent ECs induced a senescence-like state and reduced insulin receptor substrate-1 in adipocytes, which thereby impaired insulin signaling. We generated EC-specific progeroid mice that overexpressed the dominant negative form of telomeric repeat-binding factor 2 under the control of the Tie2 promoter. EC-specific progeria impaired systemic metabolic health in mice in association with adipose tissue dysfunction even while consuming normal chow. Notably, shared circulation with EC-specific progeroid mice by parabiosis sufficiently transmitted the metabolic disorders into wild-type recipient mice. Our data provides direct evidence that EC senescence impairs systemic metabolic health, and thus establishes EC senescence as a bona fide risk for age-related metabolic disease.

Vascular senescence is closely associated with individual ageing, while its causative role remains unclear. Here Barinda et al. generate endothelial cell-specific progeroind mice, and reveal that endothelial cell senescence directly induces metabolic disorders through senescence-messaging secretomes.

Details

Title
Endothelial progeria induces adipose tissue senescence and impairs insulin sensitivity through senescence associated secretory phenotype
Author
Jeffilano, Barinda Agian 1   VIAFID ORCID Logo  ; Ikeda Koji 2 ; Bayu, Nugroho Dhite 2   VIAFID ORCID Logo  ; Arby, Wardhana Donytra 2 ; Sasaki Naoto 3 ; Honda Sakiko 4 ; Urata Ryota 4 ; Matoba Satoaki 4 ; Hirata Ken-ichi 5 ; Emoto Noriaki 6 

 Kobe Pharmaceutical University, Laboratory of Clinical Pharmaceutical Science, Kobe, Japan (GRID:grid.411100.5) (ISNI:0000 0004 0371 6549); Universitas Indonesia, Department of Pharmacology and Therapeutic, Faculty of Medicine, Jakarta, Indonesia (GRID:grid.9581.5) (ISNI:0000000120191471) 
 Kobe Pharmaceutical University, Laboratory of Clinical Pharmaceutical Science, Kobe, Japan (GRID:grid.411100.5) (ISNI:0000 0004 0371 6549) 
 Kobe Pharmaceutical University, Laboratory of Medical Pharmaceutics, Kobe, Japan (GRID:grid.411100.5) (ISNI:0000 0004 0371 6549) 
 Kyoto Prefectural University Graduate School of Medical Science, Department of Cardiology, Kyoto, Japan (GRID:grid.258797.6) (ISNI:0000 0001 0697 4728) 
 Kobe University Graduate School of Medicine, Division of Cardiovascular Medicine, Department of Internal Medicine, Kobe, Japan (GRID:grid.31432.37) (ISNI:0000 0001 1092 3077) 
 Kobe Pharmaceutical University, Laboratory of Clinical Pharmaceutical Science, Kobe, Japan (GRID:grid.411100.5) (ISNI:0000 0004 0371 6549); Kobe University Graduate School of Medicine, Division of Cardiovascular Medicine, Department of Internal Medicine, Kobe, Japan (GRID:grid.31432.37) (ISNI:0000 0001 1092 3077) 
Publication year
2020
Publication date
2020
Publisher
Nature Publishing Group
e-ISSN
20411723
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2344544677
Copyright
© The Author(s) 2020. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.